New York, NY (Top40 Charts) The Staglin family's 21st annual
Music Festival for Brain Health on
September 19 in the Napa Valley raised $4.8 million to benefit the IMHRO/One Mind
Institute and ONE MIND™. The 21-year cumulative total, including direct contributions to ONE MIND™, and leveraged funds provided to scientists as a result of IMHRO's initial research funding from festival proceeds, has surpassed $225 million since 1995. IMHRO and ONE MIND™ together have become the nation's leading private-public mental health organizations dedicated to curing brain-related diseases, including depression, schizophrenia, traumatic brain injury and bi-polar illness, focusing on issues including funding, research, advocacy, and anti-stigma.
Co-hosts Shari and Garen Staglin, along with their children
Brandon and Shannon, Patrick Kennedy, Co-Chairman, and Pete Chiarelli, CEO of ONE MIND™, and the IMHRO Board of Directors welcomed over 500 supporters, scientists, and friends to celebrate life and raise awareness of the causes and cures for physiological brain disorders.
"Today was about celebrating and reflecting on the milestones of the past 20 years and looking forward to the upcoming successes in the next 20 years," stated Shari and Garen Staglin. "As we look forward, we see incredible momentum and anticipate important scientific breakthroughs that will unlock the mysteries of the brain and make a difference in so many lives."
The 21st Annual festival began with a scientific symposium, featuring keynote speaker Geoffrey T. Manley, MD, PhD, Chief of Neurosurgery at San Francisco General Hospital and Professor of Neurosurgery at the University of California San Francisco.
IMHRO's Scientific Advisory Board has chosen Conor Liston, MD, Ph.D., to receive the 2015 IMHRO/Janssen Rising Star Translational Research Award, and Katie McLaughlin, Ph.D., to receive the 2015 IMHRO/AIM Rising Star Award. More information on each Rising Star Award is below.
A tasting of some of the word's most acclaimed wines took place in the Staglin Family Vineyard winery caves, with hors d'oeuvres provided by Chef Sean O'Toole of celebrated TORC Napa Valley.
Melissa Etheridge then took the stage for an intimate concert among the Staglin Vineyard vines, followed by the post-concert VIP dinner featuring Top Chef Hubert Keller of Fleur Las Vegas. Generosity was evident with an impromptu fund-a-need auction that itself added $530,000 to the day's total.
Donations to the
Music Festival for Brain Health may be made on-line at www.imhro.org, or by sending a check to IMHRO, a 501 (c) (3) non-profit organization that sponsors the
Music Festival. Please mail donations to: P.O. Box 680, Rutherford, Calif., 94573. The date for the 2016
Music Festival for Brain Health has been set for Saturday,
September 17, 2016.
For more information, please call Cindy Dyar at (707) 963-4038 or email
[email protected] or visit www.music-festival.org.
One Mind
Institute (IMHRO) 2015 Rising Star Research Awards
The One Mind
Institute (IMHRO) 2015 Rising Star Research Awards are sponsored by IMHRO, Janssen Research & Development, LLC and the AIM for Mental Health campaign. These awards identify and fund critical and cutting edge research on the causes of and cures for brain disorders.
IMHRO's Scientific Advisory Board has chosen Conor Liston, MD, Ph.D., to receive the 2015 IMHRO/Janssen Rising Star Translational Research Award, and Katie McLaughlin, Ph.D., to receive the 2015 IMHRO/AIM Rising Star Award.
Dr. Liston, Ph.D. is Assistant Professor of Neuroscience and Psychiatry at the Brain and Mind Research
Institute and Department of Psychiatry, Weill Cornell Medical College. Dr. Liston's award-winning proposal, "Circuit Biomarkers for Diagnosing and Treating Neurophysiological Subtypes of Depression," addresses a critical need toward developing personalized psychiatry, aiming to understand and test treatments targeting the biological mechanisms behind distinct forms of depression.
Dr. McLaughlin, Ph.D. is Assistant Professor of Psychology at University of Washington. McLaughlin's proposal, "Neural Mechanisms of
Stress Vulnerability Underlying Anxiety and Depression in Youth," employs neuroimaging and mobile-device-enabled monitoring to better understand the biology linking the stress of adolescent life with the development of anxiety and depression.
Given the challenges of finding therapies for psychiatric disorders, the IMHRO Rising Star awards encourage the community of researchers to direct their efforts toward translational science while supporting the research of emerging leaders in the field. They also fill a critical gap of support as federal funds dedicated to research continue to decline.
"We are grateful for the Rising Star Award partnerships with Janssen Research & Development and IMHRO's AIM for Mental Health campaign, led by Susan Stilwell," stated Shari Staglin, founder and director of IMHRO. "Janssen's five year commitment and AIM's continuing campaign are vital to helping us find the causes of and cures for brain illnesses and disorders."
"Janssen is very proud to support this distinguished award now in its fifth year," stated Dr. Jeffrey Nye, Vice President of Neuroscience Innovation and Scientific Partnership Strategy at Johnson & Johnson Innovation/Janssen R&D. "Our aim is to foster the translation of targets and technologies discovered in the exploding field of neuroscience into novel treatments for psychiatric disorders."
The 2015 Rising Star Award winners were selected with the assistance and recommendations of the IMHRO scientific advisory board, which includes ten of the leading brain scientists in the world, noted for their pioneering research in their respective fields. Each Rising Star recipient will receive $250,000 to fund research for their studies.
300 DPI digital images available upon request
Recap video available at https://vimeo.com/139981901
About IMHRO/One Mind
Institute ("IMHRO")
IMHRO is committed to raising awareness and funding research to find preventions and cures for schizophrenia, major depression and bipolar disorder within a generation. IMHRO is led and supported by families and individuals whose lives have been touched by brain disorders - and who have seen how far mental health research has come in the last decade. Contributions to IMHRO have resulted in over $225 million for research, changed thousands of lives, and funded stunning discoveries for better therapies now and tomorrow. www.imhro.org
About ONE MIND™
ONE MIND™ is a new-model non-profit organization that is taking the lead role in the research, funding, marketing, and public awareness of mental illness and brain injury, by bringing together the governmental, corporate, scientific, and philanthropic communities in a concerted effort to drastically reduce the social and economic effects of mental illness and brain injury. With ONE MIND™ as the hub for open-science, big data, and research, compelling the scientific, health care, and pharmaceutical communities to collaborate completely for the common good, we can accomplish would have previously required 50 years to less than a decade. www.onemind.org
